Third line HAART in HIV-infected children

Project no.: HIV-NAT 113

This study will assess efficacy and safety of third line regimen in 150 Thai children.

Presentations:

1. Pharmacokinetics of darunavir/ritonavir in Asian HIV-1 infected children aged ≥ 6 years. [Poster #714] presented at the 18th CROI 2011. Boston, MA, USA. February 27- March 2, 2011.
2. Ananworanich J, Prasitsuebsai W, Kosalaraksa P, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Sangkla P, Suwarnlerk T, Sophonphan J, Hansudewechakul R, Wittawatmongkol O, Puthanakit T, Chokephaibulkit K. Outcomes of third-line antiretroviral therapy containing darunavir, etravirine or raltegravir in Thai children with HIV infection. Presented at 19^th International AIDS Conference, Washington DC, USA. July 22-27, 2012